BlackRock
CARL

BlackRock’s Carlsmed CARL Stock Holding History

BlackRock’s Portfolio CARL Stock Details CARL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.04M Buy
446,892
+19,418
+5% +$235K ﹤0.01% 3912
2025
Q4 		$5.28M Buy
427,474
+42,035
+11% +$560K ﹤0.01% 3818
2025
Q3 		$5.16M Buy
+385,439
New +$5.27M ﹤0.01% 3771

Other funds holding CARL

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KC
KCM Capital Shawnee, Kansas $622M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BlackRock's CARL Position: Q1 2026 in Review

BlackRock increased its Carlsmed (CARL) stake by 4.5% in Q1 2026, buying an estimated $235K and bringing the position to 446,892 shares worth $4.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3912.

BlackRock first reported a position in CARL in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.28M in Q4 2025. 66 funds tracked by Wall St. Rank hold CARL as of Q1 2026.

  • BlackRock held 446,892 shares of Carlsmed worth $4.04M as of Q1 2026.
  • BlackRock bought 19,418 Carlsmed shares in Q1 2026, an estimated $235K.
  • Carlsmed made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #3912 holding.
  • BlackRock first reported a position in Carlsmed in Q3 2025 and has held it in 3 quarters since.
  • BlackRock's Carlsmed position peaked at $5.28M in Q4 2025.
  • 66 funds tracked by Wall St. Rank held Carlsmed as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.